Obesity and severity of nocturnal desaturations have synergestic effects on the increased urinary excretion of leukotriene E4 in sleep apnea syndrome

F. Stanke-Labesque, R. Tamisier, B. Lefebrve, J. P. Baguet, N. Arnol, P. Levy, J. L. Pepin (Grenoble, France)

Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Session: Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Session type: E-Communication Session
Number: 3234
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Stanke-Labesque, R. Tamisier, B. Lefebrve, J. P. Baguet, N. Arnol, P. Levy, J. L. Pepin (Grenoble, France). Obesity and severity of nocturnal desaturations have synergestic effects on the increased urinary excretion of leukotriene E4 in sleep apnea syndrome. Eur Respir J 2008; 32: Suppl. 52, 3234

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP
Source: Eur Respir J 2007; 30: 496-500
Year: 2007



Urinary excretion of erythropoietin in sleep apnea-hypopnea syndrome
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012

Neuropeptide plasma levels in sleep apnea patients with and without excessive daytime sleepiness
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009

Sleep fragmentation and nocturnal desaturation in obstruction sleep apnoea with and without COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 573s
Year: 2002

Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea: Effect of continuous positive airway pressure treatment
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


Sleep and daytime sleepiness in upper airway resistance syndrome compared to obstructive sleep apnoea syndrome
Source: Eur Respir J 2001; 17: 838-847
Year: 2001



Peculiarities of GABA levels in plasma and urine of asthma patients with obstructive sleep apnea
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020


Renin and aldosterone levels in obstructive sleep apnea syndrome patients
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015

Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021


Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea
Source: Sleep and Breathing Conference 2021
Year: 2021



Effects of reduced lung volumes and age on oxyhemoglobin nocturnal desaturation in obstructive sleep apnea patients before and after CPAP treatment
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011

Correlations between severity of nocturnal hypoxemia and level of Galectin-3 in obstructive sleep apnea patients
Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view
Year: 2019

Association between daytime hypersomnolence and the metabolic syndrome in men with obstructive sleep apnea
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009

The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019

The factors related to the daytime hypercapnia in obstructive sleep apnea syndrome
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009

Leptin daytime urine secretion corresponds to OSA severity
Source: Eur Respir J 2004; 24: Suppl. 48, 566s
Year: 2004

Correlation between intermittent nocturnal hypercapnia and depressive symptoms in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011


Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 574s
Year: 2002

Plasma orexin-A levels in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007